ArticleScientific reports2025
Physiological characteristics and green production NiO nanoparticle synthesis employing Moringa Oleifera lam extract to assess in vitro cytotoxicity, antibacterial.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Eco-Friendly Synthesis ofBioinorganic chemistry and applications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Moringa Oleifera is a medicinal plant that is used in the production of cytotoxic agents, which are used in cancer treatment to prevent the division and spread of cancer cells. The present study investigates the cytotoxic activity of NiO nanoparticles (NiONPs) produced by means of green synthesis using Moringa Oleifera on human cancer cell lines (HEP-G2). The antibacterial activity of these nanoparticles was also evaluated in relation to the carbapenem (CRO), chloramphenicol (C), ampicillin (AM), cephalothin (KF) and meropenem (MEM) antibiotics, as well as Gram-positive Streptococcus mutans (S. mutans) (+) and Gram-negative Escherichia coli (E. coli) (-) bacteria. NiONPs demonstrated a high cytotoxic value of 91.05% against HEP-G2 cancer cells. The study established that 1 µg/ml resulted in 85.2% of HEP-G2 cancer cell death. The study demonstrated high levels of antibacterial resistance at low concentrations (0.0315 µg/mol). The high sensitivity of the bacteria was determined for Chloramphenicol (C) and Meropenem (MEM) for S. mutans and for all antibiotics for E. coli bacteria. It was demonstrated that S. mutans and E. coli bacteria exhibited high susceptibility to only chloramphenicol (C) and meropenem (MEM) antibiotics. The NiONPs demonstrated a spherical morphology, with grain sizes ranging from 24 to 40 nm, and a surface plasma resonance (SPR) peak at 356 nm. NiONPs prepared with Moringa oleifera plant are suitable for biomedical applications due to their very high level of toxicity against HEP-G2, strong antibiotic sensitivity and antimicrobial activity against S. mutans and E. coli.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.